DHI
27
-9
FFIV
63
2
VLO
26
3
URBN
75
8
DNB
54
-4
ITW
43
-2
LH
33
-2
EQT
50
3
XEL
51
3
KSS
38
2
OXY
34
-8
PSA
45
2
NTRS
39
2
HIG
50
2
BIIB
39
2
CI
38
3
NUE
39
2
MSFT
53
-2
TAP
54
-3
WBA
38
-3
DHI
27
-9
FFIV
63
2
VLO
26
3
URBN
75
8
DNB
54
-4
ITW
43
-2
LH
33
-2
EQT
50
3
XEL
51
3
KSS
38
2
OXY
34
-8
PSA
45
2
NTRS
39
2
HIG
50
2
BIIB
39
2
CI
38
3
NUE
39
2
MSFT
53
-2
TAP
54
-3
WBA
38
-3
Financhill
Back

Adverum Biotechnologies 10K Form

Sell
27

ADVM
Adverum Biotechnologies

Last Price:
$4.74
Seasonality Move:
20.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADVM News And Ratings

See the #1 stock for the next 7 days that we like better than ADVM

ADVM Financial Statistics

Sales & Book Value

Annual Sales: $3.6M
Cash Flow: $-21.3M
Price / Cash Flow: 0
Annual Sales: $6.93
Price / Book: 0.68

Profitability

EPS (TTM): -6.01000
Net Income (TTM): $-94.1M
Gross Margin: $480K
Return on Equity: -69.14%
Return on Assets: -41.8%

Adverum Biotechnologies Earnings Forecast

Key Adverum Biotechnologies Financial Ratios

  • The Gross Profit Margin over the past 1 years for ADVM is 100.00%.
  • The Selling, General & Administrative Expenses for ADVM have been equal to 1,386.53% of Gross Profit Margin.
  • The Research & Development expenses have been 2,157.67% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of ADVM is -3,254.58% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 5 years.

Adverum Biotechnologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ADVM
CUSIP: 00773U
Website: adverum.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.82
Quick Ratio: 5.54

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ADVM Technical Analysis vs Fundamental Analysis

Sell
27
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy or a Sell?